Effects of Pre-emptive Scalp Infiltration With Ketorolac and Ropivacaine for Post-craniotomy Pain
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The PAINLESS study is a single-center, prospective, randomized, open-label, blinded-endpoint
(PROBE) controlled clinical study to compare the efficacy and safety of pre-emptive scalp
infiltration with ropivacaine plus ketorolac and ropivacaine alone for postoperative pain
relief in adults undergoing elective supratentorial craniotomies.